1.62
Precedente Chiudi:
$1.625
Aprire:
$1.63
Volume 24 ore:
38,390
Relative Volume:
0.11
Capitalizzazione di mercato:
$42.88M
Reddito:
$4.99M
Utile/perdita netta:
$-28.29M
Rapporto P/E:
-1.5388
EPS:
-1.0528
Flusso di cassa netto:
$-36.20M
1 W Prestazione:
+0.62%
1M Prestazione:
+1.25%
6M Prestazione:
+26.56%
1 anno Prestazione:
-14.74%
Lava Therapeutics Nv Stock (LVTX) Company Profile
Nome
Lava Therapeutics Nv
Settore
Industria
Telefono
31 6 3000 3035
Indirizzo
YALELAAN 62, UTRECHT
Confronta LVTX con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
|
LVTX
Lava Therapeutics Nv
|
1.63 | 42.75M | 4.99M | -28.29M | -36.20M | -1.0528 |
|
VRTX
Vertex Pharmaceuticals Inc
|
426.23 | 109.11B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
641.92 | 68.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
432.67 | 60.25B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
825.18 | 50.39B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
186.14 | 40.44B | 447.02M | -1.18B | -868.57M | -6.1812 |
Lava Therapeutics Nv Stock (LVTX) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2024-12-12 | Downgrade | Leerink Partners | Outperform → Market Perform |
| 2024-12-11 | Downgrade | JMP Securities | Mkt Outperform → Mkt Perform |
| 2022-10-25 | Iniziato | H.C. Wainwright | Buy |
| 2021-04-19 | Iniziato | JP Morgan | Overweight |
| 2021-04-19 | Iniziato | Jefferies | Buy |
| 2021-04-19 | Iniziato | SVB Leerink | Outperform |
Mostra tutto
Lava Therapeutics Nv Borsa (LVTX) Ultime notizie
Will LAVA Therapeutics N.V. stock benefit from green energy trendsBond Market & Weekly Momentum Stock Picks - newser.com
How LAVA Therapeutics N.V. stock valuations compare to rivalsJuly 2025 Snapshot & Free Technical Pattern Based Buy Signals - newser.com
Ranking LAVA Therapeutics N.V. among high performing stocks via toolsTrade Exit Report & Community Consensus Picks - newser.com
Can LAVA Therapeutics N.V. (4PKB) stock expand revenue streamsTrade Entry Report & Reliable Price Breakout Signals - newser.com
Why hedge funds are buying LAVA Therapeutics N.V. stockJuly 2025 Recap & Low Risk Growth Stock Ideas - newser.com
How to track smart money flows in LAVA Therapeutics N.V.Weekly Trade Recap & Breakout Confirmation Alerts - newser.com
Heatmap analysis for LAVA Therapeutics N.V. and competitorsJuly 2025 Closing Moves & Community Verified Trade Signals - newser.com
What indicators show strength in LAVA Therapeutics N.V.July 2025 PostEarnings & Real-Time Volume Trigger Notifications - newser.com
Is LAVA Therapeutics N.V. showing signs of accumulationJuly 2025 Patterns & Intraday High Probability Setup Alerts - newser.com
Reversal indicators forming on LAVA Therapeutics N.V. stock2025 Volatility Report & Weekly High Return Opportunities - newser.com
Custom strategy builders for tracking LAVA Therapeutics N.V.Swing Trade & Daily Price Action Insights - newser.com
Can LAVA Therapeutics N.V. hit a new high this monthJuly 2025 News Drivers & Accurate Entry and Exit Point Alerts - newser.com
Analyzing LAVA Therapeutics N.V. with risk reward ratio chartsTrade Exit Summary & Real-Time Stock Entry Alerts - newser.com
How analysts revise price targets for LAVA Therapeutics N.V. (4PKB) stock2025 Year in Review & Fast Exit and Entry Strategy Plans - newser.com
Advanced analytics toolkit walkthrough for LAVA Therapeutics N.V.Market Growth Report & Stepwise Trade Signal Implementation - newser.com
Historical volatility pattern of LAVA Therapeutics N.V. visualizedWeekly Profit Recap & Verified Trade Idea Suggestions - newser.com
Price momentum metrics for LAVA Therapeutics N.V. explained2025 Price Targets & Safe Entry Trade Signal Reports - newser.com
Published on: 2025-10-31 00:32:41 - newser.com
What analysts say about LAVA Therapeutics NV 4PKB stockInsider Trading Activity & Low Cost Portfolio Tips - earlytimes.in
What hedge fund activity signals for LAVA Therapeutics N.V. stockMarket Trend Report & AI Powered Buy/Sell Recommendations - fcp.pa.gov.br
Lava Therapeutics Nv Azioni (LVTX) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Lava Therapeutics Nv Azioni (LVTX) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Cooperatieve Gilde Healthcare | 10% Owner |
Oct 16 '25 |
Sale |
1.49 |
690,239 |
1,028,456 |
4,128,912 |
| Cooperatieve Gilde Healthcare | 10% Owner |
Oct 14 '25 |
Sale |
1.51 |
227,341 |
343,285 |
5,019,151 |
| Cooperatieve Gilde Healthcare | 10% Owner |
Oct 13 '25 |
Sale |
1.54 |
47,686 |
73,436 |
5,246,492 |
| Cooperatieve Gilde Healthcare | 10% Owner |
Oct 10 '25 |
Sale |
1.55 |
49,869 |
77,297 |
5,294,178 |
| Cooperatieve Gilde Healthcare | 10% Owner |
Oct 09 '25 |
Sale |
1.56 |
48,169 |
75,144 |
5,344,047 |
| Cooperatieve Gilde Healthcare | 10% Owner |
Oct 08 '25 |
Sale |
1.57 |
28,954 |
45,458 |
5,392,216 |
| Versant Venture Capital VI, L. | 10% Owner |
Sep 19 '25 |
Sale |
1.40 |
2,370,533 |
3,322,065 |
0 |
| Versant Venture Capital VI, L. | 10% Owner |
Sep 19 '25 |
Sale |
1.40 |
532,870 |
746,764 |
0 |
| Versant Venture Capital VI, L. | 10% Owner |
Sep 17 '25 |
Sale |
1.49 |
362,806 |
540,291 |
2,736,644 |
| Versant Venture Capital VI, L. | 10% Owner |
Sep 18 '25 |
Sale |
1.44 |
366,111 |
527,859 |
2,370,533 |
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):